Arlette Garnier-Suillerot

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Physiology

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Salerno Milena; Yahia Dalila; Dzamitika Simplice; de Vries Elisabeth; Pereira-Maia Elene; Garnier-Suillerot Arlette
Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells.
Silva Heveline; Valério Barra Carolina; França da Costa Cristiane; de Almeida Mauro Vieira; César Eloi Teixeira; Silveira Josianne N; Garnier-Suillerot Arlette; Silva de Paula Flávia Cristina; Pereira-Maia Elene Cristina; Fontes Ana Paula Soares
Impact of the carbon chain length of novel platinum complexes derived from N-alkyl-propanediamines on their cytotoxic activity and cellular uptake.
Carvalho Júnior A D; Vieira F P; Melo V J de; Lopes M T P; Silveira J N; Ramaldes G A; Garnier-Suillerot A; Pereira-Maia E C; Oliveira M C de
Preparation and cytotoxicity of cisplatin-containing liposomes.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Arlette Garnier-Suillerot (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Salerno Milena; Yahia Dalila; Dzamitika Simplice; de Vries Elisabeth; Pereira-Maia Elene; Garnier-Suillerot Arlette
Impact of intracellular chloride concentration on cisplatin accumulation in sensitive and resistant GLC4 cells.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2009;14(1):123-32.
2008: Silva Heveline; Valério Barra Carolina; França da Costa Cristiane; de Almeida Mauro Vieira; César Eloi Teixeira; Silveira Josianne N; Garnier-Suillerot Arlette; Silva de Paula Flávia Cristina; Pereira-Maia Elene Cristina; Fontes Ana Paula Soares
Impact of the carbon chain length of novel platinum complexes derived from N-alkyl-propanediamines on their cytotoxic activity and cellular uptake.
Journal of inorganic biochemistry 2008;102(4):767-72.
2007: Carvalho Júnior A D; Vieira F P; Melo V J de; Lopes M T P; Silveira J N; Ramaldes G A; Garnier-Suillerot A; Pereira-Maia E C; Oliveira M C de
Preparation and cytotoxicity of cisplatin-containing liposomes.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2007;40(8):1149-57.
2007: Marbeuf-Gueye Carole; Stierle Vérene; Sudwan Paiwan; Salerno Milena; Garnier-Suillerot Arlette
Perturbation of membrane microdomains in GLC4 multidrug-resistant lung cancer cells--modification of ABCC1 (MRP1) localization and functionality.
The FEBS journal 2007;274(6):1470-80.
2007: Saengkhae Chantarawan; Salerno Milena; Adès Dominique; Siove Alain; Le Moyec Laurence; Migonney Véronique; Garnier-Suillerot Arlette
Ability of carbazole salts, inhibitors of Alzheimer beta-amyloid fibril formation, to cross cellular membranes.
European journal of pharmacology 2007;559(2-3):124-31.
2007: Teodori Elisabetta; Martelli Cecilia; Salerno Milena; Darghal Nacira; Dei Silvia; Garnier-Suillerot Arlette; Gualtieri Fulvio; Manetti Dina; Scapecchi Serena; Romanelli Maria Novella
Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitors.
Journal of medicinal chemistry 2007;50(4):599-602.
2006: Darghal Nacira; Garnier-Suillerot Arlette; Salerno Milena
Mechanism of thioflavin T accumulation inside cells overexpressing P-glycoprotein or multidrug resistance-associated protein: role of lipophilicity and positive charge.
Biochemical and biophysical research communications 2006;343(2):623-9.
2006: Dzamitika Simplice A; Falcão Camila A B; de Oliveira Fernanda B; Marbeuf Carole; Garnier-Suillerot Arlette; Demicheli Cynthia; Rossi-Bergmann Bartira; Frézard Frédéric
Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
Chemico-biological interactions 2006;160(3):217-24.
2006: Dzamitika Simplice; Salerno Milena; Pereira-Maia Elene; Le Moyec Laurence; Garnier-Suillerot Arlette
Preferential energy- and potential-dependent accumulation of cisplatin-gutathione complexes in human cancer cell lines (GLC4 and K562): A likely role of mitochondria.
Journal of bioenergetics and biomembranes 2006;38(1):11-21.
2005: Teodori Elisabetta; Dei Silvia; Garnier-Suillerot Arlette; Gualtieri Fulvio; Manetti Dina; Martelli Cecilia; Romanelli Maria Novella; Scapecchi Serena; Sudwan Paiwan; Salerno Milena
Exploratory chemistry toward the identification of a new class of multidrug resistance reverters inspired by pervilleine and verapamil models.
Journal of medicinal chemistry 2005;48(23):7426-36.
2005: Dei Silvia; Budriesi Roberta; Sudwan Paiwan; Ferraroni Marta; Chiarini Alberto; Garnier-Suillerot Arlette; Manetti Dina; Martelli Cecilia; Scapecchi Serena; Teodori Elisabetta
Diphenylcyclohexylamine derivatives as new potent multidrug resistance (MDR) modulators.
Bioorganic & medicinal chemistry 2005;13(4):985-98.
2004: Reungpatthanaphong Paiboon; Marbeuf-Gueye Carole; Le Moyec Laurence; Salerno Milena; Garnier-Suillerot Arlette
Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts.
Journal of bioenergetics and biomembranes 2004;36(6):533-43.
2004: Salerno M; Loechariyakul P; Saengkhae C; Garnier-Suillerot A
Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin.
Biochemical pharmacology 2004;68(11):2159-65.
2004: Tarasiuk Jolanta; Majewska Ewelina; Seksek Olivier; Rogacka Dorota; Antonini Ippolito; Garnier-Suillerot Arlette; Borowski Edward
The role of structural factors in the kinetics of cellular uptake of pyrazoloacridines and pyrazolopyrimidoacridines: implications for overcoming multidrug resistance towards leukaemia K562/DOX cells.
Biochemical pharmacology 2004;68(9):1815-23.
2003: Saengkhae Chantarawan; Loetchutinat Chatchanok; Garnier-Suillerot Arlette
Kinetic analysis of rhodamines efflux mediated by the multidrug resistance protein (MRP1).
Biophysical journal 2003;85(3):2006-14.
2003: Seigneuret Michel; Garnier-Suillerot Arlette
A structural model for the open conformation of the mdr1 P-glycoprotein based on the MsbA crystal structure.
The Journal of biological chemistry 2003;278(32):30115-24.
2003: Cesar Elói Teixeira; de Almeida Mauro Vieira; Fontes Ana Paula Soares; Pereira Maia Elene Cristina; Garnier-Suillerot Arlette; Rúbia Costa Couri Mara; de Castro Antunes Felício Emanoel
Synthesis, characterization, cytotoxic activity, and cellular accumulation of dinuclear platinum complexes derived from N,N'-di-(2-aminoethyl)-1,3-diamino-2-propanol, aryl substituted N-benzyl-1,4-butanediamines, and N-benzyl-1,6-hexanediamines.
Journal of inorganic biochemistry 2003;95(4):297-305.
2003: Pereira-Maia Elene; Garnier-Suillerot Arlette
Impaired hydrolysis of cisplatin derivatives to aquated species prevents energy-dependent uptake in GLC4 cells resistant to cisplatin.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 2003;8(6):626-34.
2003: Haj Hayet Tayeb-Bel; Salerno Milena; Priebe Waldemar; Kozlowski Henryk; Garnier-Suillerot Arlette
New findings in the study on the intercalation of bisdaunorubicin and its monomeric analogues with naked and nucleus DNA.
Chemico-biological interactions 2003;145(3):349-58.
2003: Fiallo Marina M L; Deydier Eric; Bracci Michela; Garnier-Suillerot Arlette; Halvorsen Karin
Mitomycin antitumor compounds. 2. Interaction of transition metal ions with mitomycin C. Solution structure and biological activity of a Pd(2+)-MMC complex.
Journal of medicinal chemistry 2003;46(9):1683-9.
2003: Saengkhae Chantarawan; Loetchutinat Chatchanok; Garnier-Suillerot Arlette
Kinetic analysis of fluorescein and dihydrofluorescein effluxes in tumour cells expressing the multidrug resistance protein, MRP1.
Biochemical pharmacology 2003;65(6):969-77.
2003: Loetchutinat Chatchanok; Saengkhae Chantarawan; Marbeuf-Gueye Carole; Garnier-Suillerot Arlette
New insights into the P-glycoprotein-mediated effluxes of rhodamines.
European journal of biochemistry / FEBS 2003;270(3):476-85.
2003: Salerno Milena; Garnier-Suillerot Arlette
Resistance to arsenic- and antimony-based drugs.
Bioinorganic chemistry and applications 2003;():189-98.
2002: Demicheli Cynthia; Frézard Frédéric; Lecouvey Marc; Garnier-Suillerot Arlette
Antimony(V) complex formation with adenine nucleosides in aqueous solution.
Biochimica et biophysica acta 2002;1570(3):192-8.
2002: Salerno Milena; Petroutsa Maria; Garnier-Suillerot Arlette
The MRP1-mediated effluxes of arsenic and antimony do not require arsenic-glutathione and antimony-glutathione complex formation.
Journal of bioenergetics and biomembranes 2002;34(2):135-45.
2002: Salerno Milena; Przewloka Teresa; Fokt Izabela; Priebe Waldemar; Garnier-Suillerot Arlette
Preferential efflux by P-glycoprotein, but not MRP1, of compounds containing a free electron donor amine.
Biochemical pharmacology 2002;63(8):1471-9.
2002: Tarasiuk J; Stefanska B; Plodzich I; Tkaczyk-Gobis K; Seksek O; Martelli S; Garnier-Suillerot A; Borowski E
Anthrapyridones, a novel group of antitumour non-cross resistant anthraquinone analogues. Synthesis and molecular basis of the cytotoxic activity towards K562/DOX cells.
British journal of pharmacology 2002;135(6):1513-23.
2002: Vergote Jackie; Moretti Jean Luc; Kouyoumdjian Jean Claude; Garnier-Suillerot Arlette
MRP1 modulation by PAK-104P: detection with technetium-99m-MIBI in cultured lung tumor cells.
Anticancer research 2002;22(1A):251-6.
2001: Mouzopoulou B; Kozlowski H; Katsaros N; Garnier-Suillerot A
Structural characterization of Ru-bleomycin complexes by resonance Raman, circular dichroism, and NMR spectroscopy.
Inorganic chemistry 2001;40(27):6923-9.
2001: Drechsel H; Fiallo M; Garnier-Suillerot A; Matzanke B F; Schünemann V
Spectroscopic studies on iron complexes of different anthracyclines in aprotic solvent systems.
Inorganic chemistry 2001;40(21):5324-33.
2001: Dei S; Teodori E; Garnier-Suillerot A; Gualtieri F; Scapecchi S; Budriesi R; Chiarini A
Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative.
Bioorganic & medicinal chemistry 2001;9(10):2673-82.
2001: Loetchutinat C; Heywang C; Priebe W; Garnier-Suillerot A
The absence of stereoselective P-glycoprotein- and multidrug resistance-associated protein-mediated transport of daunorubicin.
Biochemical pharmacology 2001;62(5):561-7.
2001: Loetchutinat C; Priebe W; Garnier-Suillerot A
Drug sequestration in cytoplasmic organelles does not contribute to the diminished sensitivity of anthracyclines in multidrug resistant K562 cells.
European journal of biochemistry / FEBS 2001;268(16):4459-67.
2001: Mankhetkorn S; Teodori E; Garnier-Suillerot A
Fluorescent verapamil analogue for monitoring acidic intracellular organelles in multidrug resistant and sensitive cells.
Chemico-biological interactions 2001;137(1):1-13.
2001: Salerno M; Garnier-Suillerot A
Kinetics of glutathione and daunorubicin efflux from multidrug resistance protein overexpressing small-cell lung cancer cells.
European journal of pharmacology 2001;421(1):1-9.
2001: Frézard F; Pereira-Maia E; Quidu P; Priebe W; Garnier-Suillerot A
P-glycoprotein preferentially effluxes anthracyclines containing free basic versus charged amine.
European journal of biochemistry / FEBS 2001;268(6):1561-7.
2001: Fiallo M M; Kozlowski H; Garnier-Suillerot A
Mitomycin antitumor compounds. Part 1. CD studies on their molecular structure.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;12(4):487-94.
2001: Tkaczyk-Gobis K; Tarasiuk J; Seksek O; Stefanska B; Borowski E; Garnier-Suillerot A
Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
European journal of pharmacology 2001;413(2-3):131-41.
2001: Garnier-Suillerot A; Marbeuf-Gueye C; Salerno M; Loetchutinat C; Fokt I; Krawczyk M; Kowalczyk T; Priebe W
Analysis of drug transport kinetics in multidrug-resistant cells: implications for drug action.
Current medicinal chemistry 2001;8(1):51-64.
2000: Marbeuf-Gueye C; Priebe W; Garnier-Suillerot A
Multidrug resistance protein functionality: no effect of intracellular or extracellular pH changes.
Biochemical pharmacology 2000;60(10):1485-9.
2000: Marbeuf-Gueye C; Salerno M; Quidu P; Garnier-Suillerot A
Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
European journal of pharmacology 2000;391(3):207-16.
1999: Teodori E; Ettori D; Garnier-Suillerot A; Gualtieri F; Manetti D; Romanelli M N; Scapecchi S
Synthesis and binding properties of photoactivable biotin-conjugated verapamil derivatives for the study of P-170 glycoprotein.
Bioorganic & medicinal chemistry 1999;7(9):1873-80.
1999: Fiallo M M; Drechsel H; Garnier-Suillerot A; Matzanke B F; Kozlowski H
Solution structure of iron(III)-anthracycline complexes.
Journal of medicinal chemistry 1999;42(15):2844-51.
1999: Mankhetkorn S; Teodori E; Garnier-Suillerot A
Partial inhibition of the P-glycoprotein-mediated transport of anthracyclines in viable resistant K562 cells after irradiation in the presence of a verapamil analogue.
Chemico-biological interactions 1999;121(2):125-40.
1999: Marbeuf-Gueye C; Ettori D; Priebe W; Kozlowski H; Garnier-Suillerot A
Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein.
Biochimica et biophysica acta 1999;1450(3):374-84.
1999: Fiallo M M; Garnier-Suillerot A; Matzanke B; Kozlowski H
How Fe3+ binds anthracycline antitumour compounds. The myth and the reality of a chemical sphinx.
Journal of inorganic biochemistry 1999;75(2):105-15.
1999: Essodaïgui M; Frézard F; Moreira E S; Dagger F; Garnier-Suillerot A
Energy-dependent efflux from Leishmania promastigotes of substrates of the mammalian multidrug resistance pumps.
Molecular and biochemical parasitology 1999;100(1):73-84.
1999: Teodori E; Dei S; Quidu P; Budriesi R; Chiarini A; Garnier-Suillerot A; Gualtieri F; Manetti D; Romanelli M N; Scapecchi S
Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range.
Journal of medicinal chemistry 1999;42(10):1687-97.
1998: Fiallo M M; Tayeb H; Suarato A; Garnier-Suillerot A
Circular dichroism studies on anthracycline antitumor compounds. Relationship between the molecular structure and the spectroscopic data.
Journal of pharmaceutical sciences 1998;87(8):967-75.
1998: Pereira E; Tarasiuk J; Garnier-Suillerot A
Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
Chemico-biological interactions 1998;114(1-2):61-76.
1998: Gallois L; Fiallo M; Garnier-Suillerot A
Comparison of the interaction of doxorubicin, daunorubicin, idarubicin and idarubicinol with large unilamellar vesicles. Circular dichroism study.
Biochimica et biophysica acta 1998;1370(1):31-40.
1998: Mankhetkorn S; Garnier-Suillerot A
The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
European journal of pharmacology 1998;343(2-3):313-21.
1998: Vergote J; Moretti J L; de Vries E G; Garnier-Suillerot A
Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
European journal of biochemistry / FEBS 1998;252(1):140-6.
1998: Essodaigui M; Broxterman H J; Garnier-Suillerot A
Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein.
Biochemistry 1998;37(8):2243-50.
1998: Marbeuf-Gueye C; Broxterman H J; Dubru F; Priebe W; Garnier-Suillerot A
Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Molecular pharmacology 1998;53(1):141-7.
1998: Frézard F; Garnier-Suillerot A
Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature.
Biochimica et biophysica acta 1998;1389(1):13-22.
1996: Gallois L; Fiallo M; Laigle A; Priebe W; Garnier-Suillerot A
The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids.
European journal of biochemistry / FEBS 1996;241(3):879-87.
1996: Mankhetkorn S; Teodori E; Scapecchi S; Garnier-Suillerot A
Study of P-glycoprotein functionality in living resistant K562 cells after photolabeling with a verapamil analogue.
Biochemical pharmacology 1996;52(2):213-7.
1996: Laigle A; Fiallo M M; Garnier-Suillerot A
Spectral shape modifications of anthracyclines bound to cell nuclei: a microspectrofluorometric study.
Chemico-biological interactions 1996;101(1):49-58.
1996: Jollès B; Laigle A; Priebe W; Garnier-Suillerot A
Comparison of DNA sequence selectivity of anthracycline antibiotics and their 3'-hydroxylated analogs.
Chemico-biological interactions 1996;100(2):165-76.
1996: Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
Molecular pharmacology 1996;49(3):532-9.
1995: Borrel M N; Fiallo M; Veress I; Garnier-Suillerot A
The effect of crown ethers, tetraalkylammonium salts, and polyoxyethylene amphiphiles on pirarubicin incorporation in K562 resistant cells.
Biochemical pharmacology 1995;50(12):2069-76.
1995: Pereira E; Teodori E; Dei S; Gualtieri F; Garnier-Suillerot A
Reversal of multidrug resistance by verapamil analogues.
Biochemical pharmacology 1995;50(4):451-7.
1994: Borrel M N; Fiallo M; Priebe W; Garnier-Suillerot A
P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells.
FEBS letters 1994;356(2-3):287-99.
1994: Borrel M N; Pereira E; Fiallo M; Garnier-Suillerot A
Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.
European journal of biochemistry / FEBS 1994;223(1):125-33.
1994: Pereira E; Garnier-Suillerot A
Correlation between the short-term measurements of drug accumulation in living cells and the long-term growth inhibition.
Biochemical pharmacology 1994;47(10):1851-7.
1994: Pereira E; Borrel M N; Fiallo M; Garnier-Suillerot A
Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells.
Biochimica et biophysica acta 1994;1225(2):209-16.
1993: Fiallo M; Laigle A; Garnier-Suillerot A; Amirand C; Ballini J P; Chinsky L; Duquesne M; Jolles B; Sureau F; Turpin P Y
Interactions of iron-anthracycline complexes with living cells: a microspectrofluorometric study.
Biochimica et biophysica acta 1993;1177(3):236-44.
1993: Tarasiuk J; Foucrier J; Garnier-Suillerot A
Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cells.
Biochemical pharmacology 1993;45(9):1801-8.
1993: Fiallo M; Laigle A; Borrel M N; Garnier-Suillerot A
Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells.
Biochemical pharmacology 1993;45(3):659-65.
1992: Tarasiuk J; Garnier-Suillerot A; Stefanska B; Borowski E
The essential role of anthraquinones as substrates for NADH dehydrogenase in their redox cycling activity.
Anti-cancer drug design 1992;7(4):329-40.
1992: Tarasiuk J; Garnier-Suillerot A
Thermodynamics of the anthracycline-nuclei interactions in drug-resistant and drug-sensitive K562 cells.
Biochemical pharmacology 1992;43(12):2575-80.
1992: Tarasiuk J; Garnier-Suillerot A
Kinetic parameters for the uptake of anthracycline by drug-resistant and drug-sensitive K562 cells.
European journal of biochemistry / FEBS 1992;204(2):693-8.
1991: Tarasiuk J; Liwo A; Wojtkowiak S; Dzieduszycka M; Tempczyk A; Garnier-Suillerot A; Martelli S; Borowski E
Molecular determinants of singlet oxygen binding by anthraquinones in relation to their redox cycling activity.
Anti-cancer drug design 1991;6(5):399-416.
1991: Frezard F; Garnier-Suillerot A
DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives.
Biochemistry 1991;30(20):5038-43.
1991: Frezard F; Garnier-Suillerot A
Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells.
European journal of biochemistry / FEBS 1991;196(2):483-91.
1991: Frezard F; Garnier-Suillerot A
Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and -sensitive K562 cells.
Biochimica et biophysica acta 1991;1091(1):29-35.
1990: Frezard F; Garnier-Suillerot A
Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei.
Biochimica et biophysica acta 1990;1036(2):121-7.
1989: Tarasiuk J; Frézard F; Garnier-Suillerot A; Gattegno L
Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration.
Biochimica et biophysica acta 1989;1013(2):109-17.
1989: Moustatih A; Garnier-Suillerot A
Bifunctional antitumor compounds: synthesis and characterization of a Au(III)-streptonigrin complex with thiol-modulating properties.
Journal of medicinal chemistry 1989;32(7):1426-31.
1989: Tarasiuk J; Garnier-Suillerot A; Borowski E
Lack of competition between cytochrome c and anthraquinone type drugs for the reductive sites of NADH dehydrogenase.
Biochemical pharmacology 1989;38(14):2285-9.
1989: Frézard F; Garnier-Suillerot A; Bolard J; Castagna M
Membrane-phorbol ester interactions monitored by circular dichroism.
Biochimica et biophysica acta 1989;979(3):316-20.
1989: Moustatih A; Fiallo M M; Garnier-Suillerot A
Bifunctional antitumor compounds: interaction of adriamycin with metallocene dichlorides.
Journal of medicinal chemistry 1989;32(2):336-42.
1989: Frezard F; Tarasiuk Y; Garnier-Suillerot A
[Kinetics of the incorporation of anthracyclines in human lymphocytes]
Bulletin du cancer 1989;76(8):831-4.
1988: Garnier-Suillerot A; Gattegno L
Interaction of adriamycin with human erythrocyte membranes. Role of the negatively charged phospholipids.
Biochimica et biophysica acta 1988;936(1):50-60.
1987: Kolodziejczyk P; Garnier-Suillerot A
Circular dichroism study of the interaction of mitoxantrone, ametantrone and their Pd(II) complexes with deoxyribonucleic acid.
Biochimica et biophysica acta 1987;926(3):249-57.
1986: Fiallo M M; Garnier-Suillerot A
Metal anthracycline complexes as a new class of anthracycline derivatives. Pd(II)-adriamycin and Pd(II)-daunorubicin complexes: physicochemical characteristics and antitumor activity.
Biochemistry 1986;25(4):924-30.
1986: Fiallo M M; Garnier-Suillerot A
Interaction of adriamycin with cardiolipin-containing vesicles. Evidence of an embedded site for the dihydroanthraquinone moiety.
Biochimica et biophysica acta 1986;854(1):143-6.
1985: Fiallo M M; Garnier-Suillerot A
Physicochemical studies of the iron(III)-carminomycin complex and evidence of the lack of stimulated superoxide production by NADH dehydrogenase.
Biochimica et biophysica acta 1985;840(1):91-8.
1984: Musci G; Tosi L; Desideri A; Morpurgo L; Garnier-Suillerot A
Effects of laser radiation on Rhus vernicifera laccase, Type 2 Cu-depleted laccase, and stellacyanin.
Journal of inorganic biochemistry 1984;20(1):87-92.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Arlette Garnier-Suillerot

Research Profile (preview)

Chemicals & Drugs

Physiology

Anatomy

Concepts & Ideas

Phenomena

Procedures

Genes & Molecular Sequences

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Arlette Garnier-Suillerot (preview)

All Publications